Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent NaV1.7 inhibitorsThe authors declare no competing financial interests.Electronic supplementary information (ESI) available: Assay protocols, experimental procedures, spectra of key compounds. See DOI: 10.1039/c6md00578k
Na V 1.7 is a particularly compelling target for the treatment of pain. Herein, we report the discovery and evaluation of a series of piperazine amides that exhibit state-dependent inhibition of Na V 1.7. After demonstrating significant pharmacodynamic activity with early lead compound 14 in a Na V...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!